Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$401.71
pos +0.00
+0.00%
Today's Range: 395.00 - 410.87 | BIIB Avg Daily Volume: 1,830,400
Last Update: 04/24/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 26.76%
Open: $0.00
Previous Close: $430.28
52 Week Range: $275.39 - $480.18
Oustanding Shares: 234,614,474
Market Cap: 100,949,915,873
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 9 12 12
Moderate Buy 1 1 1 1
Hold 3 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.73 1.53 1.53
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 34.78
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
34.78 34.80 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
20.35% 30.96% 241.90%
GROWTH 12 Mo 3 Yr CAGR
Revenue 46.50 0.92 0.24
Net Income 57.90 1.32 0.32
EPS 58.30 1.44 0.34
Earnings for BIIB:
EBITDA 3.41B
Revenue 8.51B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $4.12 $4.35 $16.96 $20.12
Number of Analysts 13 13 14 14
High Estimate $4.36 $4.52 $17.67 $21.83
Low Estimate $4.03 $4.22 $16.66 $19.25
Prior Year $3.49 $3.79 $13.79 $16.96
Growth Rate (Year over Year) 18.18% 14.82% 22.98% 18.64%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Biogen miss no reason to abandon big 4 of Big Pharma.
Telecom, utility and energy names led the way higher Thursday.
Gilead's Relative Strength Index slope is very strong.
Gilead's Relative Strength Index slope is very strong.
Even the second-tier biotechs are taking off.
The market is neither making progress nor shifting into a downtrend.

The Fibocall: Biogen Real Money Pro($)

After share price falls from March high, it may be ready to bounce.
An answer to those asking me what's worth buying.
But wait for a pullback before getting in.
Good buys kept getting overlooked.

Columnist Conversations

A Kinder Morgan (KMI) director unloaded 1 MM shares for $43.696 MM last week (on Apr. 20 + 21)
CMG's CEO sold 12,000 shares at $690 - $695 for a total on $8.021 MM on April 21, 2015. CMG's CFO sold 9,000 s...
Technical analysis is, in large measure, about finding repetitive price patterns and sometimes the inverse of ...
As a student of retail, I tell you this: it's weird to not see the Apple Watch in the top Best Buy and Macy's ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.